Cargando…

Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma

BACKGROUND: Protein tyrosine kinase 6 (PTK6), also known as breast tumor kinase (Brk), was a nonreceptor tyrosine kinase containing SH3, SH2, and tyrosine kinase catalytic domains. The deregulated expression of PTK6 was observed in various human cancers. However, little was known about PTK6 expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xue-Kui, Zhang, Xin-Rui, Zhong, Qian, Li, Man-Zhi, Liu, Zhi-Min, Lin, Zhi-Rui, Wu, Di, Zeng, Mu-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599503/ https://www.ncbi.nlm.nih.gov/pubmed/23497344 http://dx.doi.org/10.1186/1479-5876-11-59

Ejemplares similares

Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes
por: Tupper, J., et al.
Publicado: (2011)

PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumors
por: Peng, Maoyu, et al.
Publicado: (2014)

Overexpression of PTK6 predicts poor prognosis in bladder cancer patients
por: Xu, Xue-lian, et al.
Publicado: (2017)

Brk/PTK6 Sustains Activated EGFR Signaling through Inhibiting EGFR Degradation and Transactivating EGFR
por: Li, X, et al.
Publicado: (2012)

Brk/PTK6 and Involucrin Expression May Predict Breast Cancer Cell Responses to Vitamin D3
por: Box, Carol, et al.
Publicado: (2023)

Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro
por: Burmi, Rajpal S., et al.
Publicado: (2022)

Protein tyrosine kinase 6 is associated with nasopharyngeal carcinoma poor prognosis and metastasis
por: Liu, Li-na, et al.
Publicado: (2013)

High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis
por: Huang, Zhi-Liang, et al.
Publicado: (2015)

Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK
por: Lofgren, Kristopher A, et al.
Publicado: (2011)

Higher platelet distribution width predicts poor prognosis in laryngeal cancer
por: Zhang, Huan, et al.
Publicado: (2017)

Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma
por: Dong, Jun, et al.
Publicado: (2010)

BrkAutoDisplay: functional display of multiple exogenous proteins on the surface of Escherichia coli by using BrkA autotransporter
por: Sun, Fang, et al.
Publicado: (2015)

Role of the Brk tyrosine kinase in breast cancer progression
por: Harvey, AJ, et al.
Publicado: (2006)

SAT-133 Breast Tumor Kinase (Brk/PTK6) Mediates Triple Negative Breast Cancer Cell Migration and Taxol Resistance via SH2 Domain-Dependent Activation of RhoA and AhR
por: Dwyer, Amy Renee, et al.
Publicado: (2020)

Putting the BRK on breast cancer: From molecular target to therapeutics
por: Ang, Hui Li, et al.
Publicado: (2021)

Decreased Expression of SATB2: A Novel Independent Prognostic Marker of Worse Outcome in Laryngeal Carcinoma Patients
por: Liu, Tian-Run, et al.
Publicado: (2012)

Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma
por: Wang, Xiao-Long, et al.
Publicado: (2020)

High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis
por: Zhang, Xiao-Wen, et al.
Publicado: (2015)

Brk expression may affect the differentiation status of breast cancer cells
por: Harvey, AJ, et al.
Publicado: (2008)

CircPTK2 (hsa_circ_0003221) Contributes to Laryngeal Squamous Cell Carcinoma by the miR-1278/YAP1 Axis
por: Yang, Zhendong, et al.
Publicado: (2021)

DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis
por: Ji, Yan-Mei, et al.
Publicado: (2016)

Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
por: Wu, Zhi-Zhong, et al.
Publicado: (2020)

PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer
por: Wozniak, Darren J., et al.
Publicado: (2017)

Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer
por: Li, Yixuan, et al.
Publicado: (2021)

High serum CCL18 predicts a poor prognosis in patients with laryngeal squamous cell carcinoma
por: Wang, Juncheng, et al.
Publicado: (2019)

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate
por: Xiang, Wei, et al.
Publicado: (2022)

CD163+ Tumor-Associated Macrophages Correlated with Poor Prognosis and Cancer Stem Cells in Oral Squamous Cell Carcinoma
por: He, Ke-Fei, et al.
Publicado: (2014)

Lower mean platelet volume predicts poor prognosis in renal cell carcinoma
por: Yun, Zhi-yuan, et al.
Publicado: (2017)

PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma
por: Liu, Kang, et al.
Publicado: (2017)

Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer
por: Liu, Chaoqun, et al.
Publicado: (2021)

Prognostic impact of PTK6 expression in triple negative breast cancer
por: Chen, Yuexia, et al.
Publicado: (2023)

High tumor mutation burden indicates a poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Song, Jian-Ping, et al.
Publicado: (2022)

PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance
por: Tian, Xiuyun, et al.
Publicado: (2016)

Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020)

Prognosis of patients with laryngeal contact granuloma: Development and validation of RCGSG score
por: Pan, Yufei, et al.
Publicado: (2022)

Folate deficiency and aberrant expression of cell adhesion molecule 1 are potential indicators of prognosis in laryngeal squamous cell carcinoma
por: Chang, Hao, et al.
Publicado: (2016)

High-Resolution X-Ray Structure of the Trimeric Scar/WAVE-Complex Precursor Brk1
por: Linkner, Joern, et al.
Publicado: (2011)

BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration
por: Miah, Sayem, et al.
Publicado: (2014)

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022)

Over-Expression of CD200 Predicts Poor Prognosis in Cutaneous Squamous Cell Carcinoma
por: Li, Li, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ps81aj44h9bvj2601bsto3e96p